Enfusion EBIT

The latest EBIT for ENFN is $3.2M as of December 2024. That compares with $12M in the prior-year period — down 73.4% year over year. That is below the Technology sector average of $14T. Investors often review this figure alongside Enfusion's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENFN's EBIT moved from $12M to $3.2M — a 73.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Enfusion's operating scale or balance-sheet position.

Against Technology companies, ENFN currently prints $3.2M for EBIT, while the sector average sits near $14T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Enfusion's growth, margins, and balance sheet.

A EBIT figure of $3.2M for ENFN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $14T. Explore the charts below for those layers of context.

After noting ENFN's EBIT ($3.2M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.